Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis

  1. Castañón, E.
  2. Rolfo, C.
  3. Viñal, D.
  4. López, I.
  5. Fusco, J.P.
  6. Santisteban, M.
  7. Martin, P.
  8. Zubiri, L.
  9. Echeveste, J.I.
  10. Gil-Bazo, I.
Revue:
Journal of Translational Medicine

ISSN: 1479-5876

Année de publication: 2015

Volumen: 13

Número: 1

Type: Article

DOI: 10.1186/S12967-015-0622-X GOOGLE SCHOLAR lock_openAccès ouvert editor